South Coast Gynecologic Oncology, Inc.

What South Coast Gynecologic Oncology, Inc. does

South Coast Gynecologic Oncology, Inc. (SCGOI) is a physician-owned private medical practice headquartered in San Diego, California, founded in 2004 by Dr. Afshin Bahador after his fellowship at Los Angeles County-USC Medical Center and prior role as Section Head of Gynecologic Oncology at City of Hope Cancer Center. The practice delivers comprehensive gynecologic oncology care to patients with cancers of the uterus, ovaries, fallopian tubes, peritoneum, vulva, vagina, and gestational trophoblastic disease, plus complex benign gynecologic surgery (endometriosis, fibroids, Placenta Accreta Spectrum). Its clinical service line spans surgery — including da Vinci Xi robotic-assisted minimally invasive procedures, hysterectomy, tumor debulking, and complex pelvic surgery — alongside chemotherapy (platinum agents, taxanes), PARP inhibitors, immunotherapy (pembrolizumab), radiation coordination, and survivorship surveillance, delivered via a monthly multidisciplinary tumor board.

The practice operates from two San Diego locations — a Mission Valley headquarters (new as of November 1, 2024) at 9095 Rio San Diego and a North County satellite at 9339 Genesee Ave — and is affiliated with Sharp Hospital and Scripps (including Scripps MD Anderson) for inpatient surgical privileges and hospital-based infusion. The clinical team comprises two named gynecologic oncologists (Dr. Bahador, Dr. Heidi Chang), additional robotic surgeons (Drs. Charo and Nyakudarika), two physician assistants, a nurse practitioner, and a practice administrator, with patient acquisition driven by physician referrals from OB/GYNs and primary care, hospital affiliations, and a FollowMyHealth patient portal for secure messaging.

SCGOI generates revenue from professional services — consultations, second opinions, surgery, chemotherapy/immunotherapy administration, and survivorship visits — billed through insurance, Medicare, and Medicaid (pricing not publicly disclosed). The firm has no external funding, no parent company, no subsidiaries, and no AI or proprietary technology platforms; its primary assets are its clinical talent, the 3,000+ da Vinci procedures performed by Dr. Bahador, and 15 consecutive years of San Diego Magazine Top Doctor recognition. The practice was founded in 2004 and continues to operate with 11 employees.

Name

South Coast Gynecologic Oncology, Inc.

Legal name

South Coast Gynecologic Oncology, Inc.

Website

https://scgoi.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

South Coast Gynecologic Oncology, Inc. is a physician-owned private gynecologic oncology practice in San Diego, California, founded in 2004 by Dr. Afshin Bahador. The practice provides surgical, chemotherapy, immunotherapy, and survivorship care to patients with gynecologic cancers and complex benign gynecologic conditions across two San Diego locations.

Ownership category

akta.pro rank

Product category

Gynecologic Oncology Services

NAICS

Offices of Physicians (except Mental Health Specialists) (621111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Gynecologic Oncology (HLAKAJAD)

akta.pro secondary industries

Gynecologic Oncology (HLAKAFAF), Medical Oncology (HLAKAFAB)

Keywords

• Gynecologic oncology care
• Robotic-assisted surgery
• Cancer chemotherapy services
• Gynecologic cancer treatment
• Minimally invasive surgery

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Medical Consultation Services: New patient consultations and second opinion appointments for gynecologic cancer diagnosis and treatment planning.
2. Surgical Procedures: Surgical services including robotic-assisted surgery, hysterectomy, tumor debulking, and complex pelvic surgery.
3. Chemotherapy and Immunotherapy Administration: Administer chemotherapy agents (carboplatin, cisplatin, paclitaxel, doxorubicin, PARP inhibitors) and immunotherapy drugs (pembrolizumab) for treatment of gynecologic cancers.
4. Survivorship Surveillance: Ongoing follow-up care and monitoring for cancer survivors post-treatment.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

South Coast Gynecologic Oncology is a private medical practice providing comprehensive diagnosis, surgical treatment (including da Vinci robotic-assisted procedures), chemotherapy, immunotherapy, and survivorship surveillance for patients with gynecologic cancers (ovarian, uterine/endometrial, cervical, vulvar, and vaginal) and complex gynecologic conditions such as endometriosis, fibroids, and Placenta Accreta Spectrum. Care is delivered by fellowship-trained gynecologic oncologists and advanced practice providers across two San Diego office locations in coordination with Sharp and Scripps hospitals.

Product overview

South Coast Gynecologic Oncology, Inc. is a private medical practice providing comprehensive gynecologic oncology care through a multidisciplinary team approach. The practice offers treatment across five core cancer types: ovarian, vulvar, cervical, endometrial (uterine), and vaginal cancers. Treatment services include surgery (with da Vinci robotic-assisted surgery), chemotherapy (including targeted therapies and immunotherapy), radiation therapy coordination, and follow-up survivorship care. Additional specialized procedures include cold knife conization, CO2 laser surgery, and colposcopy. The practice operates as a unified service offering rather than a platform with separate modules, integrating all cancer care services through physician-led teams including gynecologic oncologists and physician assistants.

Differentiator

Problem solved

Functional benefit

Products and services

• Ovarian Cancer Treatment

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature3 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Women's Cancer Center of Nevada: Private specialty practice focused exclusively on gynecologic oncology with multiple fellowship-trained surgeons delivering surgery, chemotherapy, and survivorship care — a near-identical operating model to SCGOI in a different metro.
• Hoag Gynecologic Oncology: Hoag Hospital's gynecologic oncology program offers the same combination of robotic surgery, chemotherapy, and multidisciplinary tumor board care for ovarian, endometrial, and cervical cancers in Southern California, directly overlapping SCGOI's clinical offering and patient geography.

Regional players

• Scripps MD Anderson Cancer Center: San Diego-affiliated comprehensive cancer program with gynecologic oncology services that is both an SCGOI hospital partner (current) and a potential in-house competitor as its employed physician team grows.
• UC San Diego Moores Cancer Center: Local San Diego academic cancer center providing gynecologic oncology surgery, chemotherapy, and clinical trials that directly competes for the same regional patient and referral pool as SCGOI.
• Sharp Cancer Services (Sharp HealthCare): San Diego health system providing inpatient and outpatient oncology including gynecologic oncology — currently a hospital partner of SCGOI but capable of expanding its employed gynecologic oncologist team to internalize referrals.
• Palo Alto Medical Foundation (Sutter Health) Gynecologic Oncology: California-based multi-specialty medical group with fellowship-trained gynecologic oncologists providing the same surgical and chemotherapy service line as SCGOI to a Northern California patient population.

Broad incumbents

• City of Hope: National cancer center with a dedicated gynecologic oncology department offering surgery, chemotherapy, and novel therapeutics — Dr. Bahador was previously Section Head here. Comparable specialty offering, but at significantly larger institutional scale.
• UCLA Health Gynecologic Oncology: Academic gynecologic oncology program providing the full surgical-oncology and chemotherapy service line, including minimally invasive and robotic procedures, with multidisciplinary tumor boards analogous to SCGOI's but inside a large academic system.
• Memorial Sloan Kettering Cancer Center: National leader in gynecologic oncology with high-volume robotic and complex pelvic surgery practice supported by multidisciplinary tumor boards; illustrates the academic benchmark SCGOI's clinical model approximates at smaller scale.
• Cleveland Clinic Gynecologic Oncology: Large integrated gynecologic oncology program offering robotic-assisted surgery, chemotherapy, and clinical trials, reflecting the kind of multi-specialty cancer center model against which private specialty practices must position.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/south-coast-gynecologic-oncology-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about South Coast Gynecologic Oncology, Inc.